Conéctate
E-mail
Contraseña
Mostrar la contraseña
Recuerde
¿Olvidó su contraseña?
Inscríbase gratis
Regístrate
Regístrate
Configuraciones
Configuraciones
Cotizaciones dinámicas 
OFFON
  1. Inicio
  2. Acciones
  3. Bélgica
  4. Euronext Bruxelles
  5. Argenx SE
  6. Noticias
  7. Otros idiomas
    ARGX   NL0010832176

ARGENX SE

(ARGX)
Cotización en tiempo real. En tiempo real Euronext Bruxelles - 26/11 17:35:21
246.4 EUR   -0.28%
29/10Los ADR europeos bajan el viernes
MT
29/10ARGENX SE : Actualizado a compra por Guggenheim
MM
28/10Argenx registra pérdidas en los tres primeros trimestres de 2021, pero los ingresos aumentan
MT
ResumenCotizacionesGráficosNoticiasRatingsAgendaEmpresaFinanzasConsensoRevisionesDerivados 
ResumenTodasRecomendaciones analistasOtros idiomasComunicadosPubls. oficialesNoticias del sector
Noticias en otros idiomas sobre ARGENX SE
22/11Farmasector zet Bel20 in het rood
22/11Verliezen worden groter
22/11Brussel licht omlaag
19/11Brussel vlak van start
16/11Brussel vlak van start
11/11Evotec wächst weiter und bestätigt Prognosen - Aktie unter Druck
10/11Argenx SE, - argenx to Present at Upcoming Investor Conferences
10/11Argenx to Present at Upcoming Investor Conferences
09/11Brussel opent vlak
09/11FDA geeft efgartigimod van Argen-x weesgeneesmiddelstatus
05/11Bel20 sluit onder 4.400 punten
05/11CFE uitblinker op groene beurs
04/11Brussel sluit opnieuw fors hoger
03/11Brussel afwachtend
03/11Brussel in afwachting van rentebesluit Fed
03/11Brussel opent iets lager
29/10European ADRs Move Lower in Friday Trading
29/10Argenx trekt Bel20 licht in het groen
29/10Brussel gaat licht omlaag
29/10Brussel lager van start
28/10Weinig spannend kwartaal Argenx
28/10AB InBev trekt Bel20 fors in het groen
28/10AB InBev trekt Bel20 stevig in het groen
28/10AB InBev zet Bel20 flink in het groen
28/10Argenx SE, - argenx Reports Third Quarter 2021 Financial Results and Provides Business ..
28/10Argenx Posts Loss for First Three Quarters of 2021, Revenue Jumps
28/10Argenx Expects Cash Burn to Double in FY21
28/10Argenx maakt voortgang met pijplijn en partnerschappen
28/10Argenx Reports Third Quarter 2021 Financial Results and Provides Business Update
28/10Argenx SE Reports Earnings Results for the Nine Months Ended September 30, 2021
21/10ARGENX : argenx to Report Third Quarter 2021 Financial Results and Business Update on Octo..
21/10ARGENX : to Report Third Quarter 2021 Financial Results and Business Update on October 28,..
08/10ARGENX : argenx to Highlight Potential First-in-Class FcRn Antagonist Efgartigimod at Upco..
08/10Argen-x presenteert onderzoeksresultaten efgartigimod
08/10argenx to Highlight Potential First-in-Class FcRn Antagonist Efgartigimod at Upcoming N..
08/10ARGENX : to Highlight Potential First-in-Class FcRn Antagonist Efgartigimod at Upcoming Ne..
07/10Jefferies zet Argen-x op kooplijst
24/09European ADRs Move Lower in Friday Trading
23/09AVIS D'ANALYSTES DU JOUR : Lufthansa, Entain, Alten, Trigano, Robertet, WDP, SKF, Covivio...
20/09ARGENX SE(NASDAQGS : ARGX) added to S&P Global BMI Index
20/09ARGENX SE(ENXTBR : ARGX) dropped from S&P Global BMI Index
03/09EVOTEC IM FOKUS : Master of the Forschung im Börsenorbit
03/09ARGENX : to Present at Upcoming Investor Conferences
02/09ARGENX : to Present at Upcoming Investor Conferences
27/08European ADRs Rise Nearly 1% Friday Morning
25/08ARGENX : Says EMA Validates Marketing Authorization Application for Rare Autoimmune Diseas..
25/08Efgartigimod van Argen-x krijgt Europese validatie
25/08ARGENX : Neuromuscular Disease Drug Accepted For European Medicines Agency Review
25/08ARGENX : Announces Validation of European Marketing Authorization Application for Efgartig..
11/08Evotec bestätigt Prognose - Investitionen belasten Ergebnis
04/08ARGENX : argenx to Present at 2021 Wedbush PacGrow Virtual Healthcare Conference
04/08ARGENX : to Present at 2021 Wedbush PacGrow Virtual Healthcare Conference
30/07ARGENX : Halfjaarlijkse Financiële verslaggeving
30/07European ADRs Drop Nearly 0.5% as Miners, Drillers Lag
29/07ARGENX : Swings to H1 Earnings as Revenue Jumps From Last Year
29/07ARGENX : argenx Reports Half Year 2021 Financial Results and Provides Second Quarter Busin..
29/07ARGENX : To Increase Spending In FY21 Amid Immunology Shift
29/07Argen-x zet sterke resultaten neer
29/07ARGENX : Reports Half Year 2021 Financial Results and Provides Second Quarter Business Upd..
29/07Argenx Se Reports Earnings Results for the Half Year Ended June 30, 2021
23/07BB BIOTECH : utile netto 1* sem a 349 mln chf (422 mln chf 1* sem 20)
22/07ANALYST RECOMMENDATIONS : Barclays, Chevron, Flutter, Netflix, Unilever...
22/07ARGENX : argenx to Report Half Year 2021 Financial Results and Second Quarter Business Upd..
22/07AVIS D'ANALYSTES DU JOUR : TotalEnergies, STMicroelectronics, Novartis, Shop Apotheke, Eas..
22/07argenx to Report Half Year 2021 Financial Results and Second Quarter Business Update on..
22/07ARGENX : to Report Half Year 2021 Financial Results and Second Quarter Business Update on ..
20/07European ADRs Up 0.5% Tuesday
20/07ANALYST RECOMMENDATIONS : Deliveroo, IBM, Intercontinental Hotels, LivaNova, Viavi...
20/07Le coronavirus contamine à nouveau les indices
20/07AVIS D'ANALYSTES DU JOUR : Richemont, Deliveroo, ArgenX, Ericsson, Zeal, ASM International..
19/07European ADRs Down 2.3% as Stock Markets Slump Monday
19/07AVIS D'ANALYSTES DU JOUR : Roche, Credit Suisse, Scor, ArgenX, Siemens Gamesa, Prosus, Pum..
19/07KBC Securities zet Argen-x op de kooplijst
19/07Le plan ne se déroule pas tout à fait comme prévu
14/07ARGENX : argenx to Host Virtual R&D Day on July 20, 2021
1  2  3  4  5  6  7  8  9  10Siguiente
Próximo evento sobre ARGENX SE
30/11/21